Form 4 for KPRX KIORA PHARMACEUTICALS INC
Accepted 2024-06-14 00:00:00 ET · period of report 2024-06-14 · accession 0001372514-24-000063 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-14 | 2024-06-14 | KPRX | Daniels Eric Joseph | Chief Development Off | P - Purchase | $5.29 | +1,431 | 11.2K | +15% | +$7,570 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-14 | P | A | 1,431 | $5.29 | 11,222 | D | — | — |